NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
8.00
+0.18 (2.30%)
Sep 8, 2026, 12:11 PM EDT - Market open
NextCure Employees
NextCure had 40 employees as of December 31, 2025. The number of employees decreased by 3 or -6.98% compared to the previous year.
Employees
40
Change (1Y)
-3
Growth (1Y)
-6.98%
Revenue / Employee
n/a
Profits / Employee
-$1,068,700
Market Cap
36.62M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 40 | -3 | -6.98% |
| Dec 31, 2024 | 43 | -39 | -47.56% |
| Dec 31, 2023 | 82 | -17 | -17.17% |
| Dec 31, 2022 | 99 | 12 | 13.79% |
| Dec 31, 2021 | 87 | -3 | -3.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Aligos Therapeutics | 82 |
| Mereo BioPharma Group | 39 |
| Quince Therapeutics | 38 |
| Kyntra Bio | 34 |
| Actinium Pharmaceuticals | 27 |
| Filana Therapeutics | 20 |
| Context Therapeutics | 15 |
| CervoMed | 15 |
NXTC News
- 4 weeks ago - Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001 - PRNewsWire
- 4 weeks ago - NextCure reports Q2 EPS ($2.80), consensus ($1.92) - TheFly
- 4 weeks ago - NextCure Quarterly report: Q2 2026 - Filings
- 4 weeks ago - NextCure Earnings release: Q2 2026 - Filings
- 4 weeks ago - NextCure Slides: Corporate presentation - Filings
- 7 weeks ago - NextCure trading resumes - TheFly
- 7 weeks ago - NextCure trading halted, volatility trading pause - TheFly
- 1 month ago - Why Is Penny Stock NextCure (NXTC) Up Today? - TipRanks